About Myasthenia Gravis

Overview

Myasthenia gravis is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles. It is characterized by muscle weakness that worsens after periods of activity and improves after periods of rest. Symptoms commonly associated with myasthenia gravis include weak eye muscles, drooping of one or both eyelids, blurred or double vision, changes in facial expressions, difficulty swallowing, shortness of breath, impaired speech, and weakness in the arms, hands, fingers, legs, and neck. In severe cases, respiratory failure may occur.

Causes and Risk Factors

Myasthenia gravis (MG)is a chronic autoimmune, neuromuscular disease that causes weakness in the skeletal muscles. The pathophysiology MG involves the failure of neuromuscular transmission due to autoantibodies binding to signaling proteins at the neuromuscular junction. This leads to increased antibody production. In patients with thymoma, there may be a deficiency of molecular components for immune tolerance.

Risk factors for MG include:

• Genetic factors: Certain genes may increase the risk of developing MG.
• Age and gender: MG is more common in women under 40 and men over 60.
• Some studies suggest a possible association between type 2 diabetes mellitus and an increased risk of MG.

It's important to note that these risk factors may increase the likelihood of developing MG, but they do not guarantee its development. It is always best to consult with a healthcare professional for a comprehensive evaluation and personalized advice.

Symptoms

The most common early symptoms of myasthenia gravis include:

• Cough
• Chest pain
• Fever

As MG progresses or reaches higher severity, the following symptoms may occur:

• Weakness of the eye muscles
• Eyelid drooping
• Blurred or double vision
• Changes in facial expressions
• Difficulty swallowing
• Shortness of breath
• Impaired speech
• Weakness in the arms, hands, fingers, legs, and neck

It's important to note that symptoms can vary widely from person to person. They often worsen during periods of activity but improve after resting. Some individuals may also experience temporary or permanent remission where symptoms disappear or lessen. In rare cases, respiratory muscle paralysis can occur, requiring assisted ventilation. It's crucial to consult with a healthcare professional for an accurate diagnosis and appropriate management.

Diagnosis

To diagnose myasthenia gravis, doctors commonly perform the following examinations, tests, and procedures:

• Physical and neurological examination: This includes reviewing your medical history and conducting a physical examination to assess muscle strength, tone, coordination, sense of touch, and eye movements.
• Edrophonium test: This test involves injecting edrophonium chloride to temporarily relieve muscle weakness and test for eye muscle weakness.
• Blood test: A blood test can detect elevated levels of acetylcholine receptor antibodies or the anti-MuSK antibody, both of which are associated with MG. However, some individuals with MG may have negative antibody results.
• Electrodiagnostics: Repetitive nerve stimulation is used to stimulate nerves with small pulses of electricity to tire specific muscles and assess nerve-muscle impairment.

To determine the stage or severity of MG, additional examinations, tests, and procedures may include:

• Single-fiber electromyography (EMG): This is a sensitive test that measures nerve-muscle impairment. It is particularly useful for diagnosing MG.
• Imaging tests: CT scans and MRI scans may be performed to check for tumors associated with MG.

It's important to note that these examinations, tests, and procedures should be conducted by healthcare professionals to ensure accurate diagnosis and staging of MG.

Treatment Options

The goals of treatment for MG are to reduce muscle weakness, improve muscle strength, and enhance overall quality of life. The following treatments are recommended to achieve these goals:

Medication Types

• Anticholinesterase medications: These medications slow the breakdown of acetylcholine, a neurotransmitter involved in muscle movement. By improving neuromuscular transmission, they increase muscle strength.
• Immunosuppressive drugs: These drugs suppress the production of abnormal antibodies that attack the neuromuscular junction. They help improve muscle strength.
• Monoclonal antibody treatment: This treatment targets the process by which acetylcholine antibodies damage the neuromuscular junction.

Therapies and Therapeutic Procedures

• Thymectomy: Surgical removal of the thymus gland can reduce symptoms and rebalance the immune system. It may lead to stable, long-lasting complete remissions in some individuals.
• Intravenous immunoglobulin therapy (IVIG): IVIG involves infusing antibodies from healthy donors into the bloodstream to temporarily modify the immune response and improve muscle strength.
• Plasma exchange (plasmapheresis): This procedure removes harmful antibodies and immune substances from the blood, temporarily improving muscle weakness.

Health Behavior Changes

• Self-care plays a crucial role in managing MG symptoms. Resting when tired, getting enough sleep, incorporating nutritious foods into the diet, avoiding extreme temperatures, and managing stress through relaxation techniques can help reduce symptom severity.

It's important to consult with a healthcare professional for personalized treatment recommendations.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.